Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Rossello FJ, Tothill RW, Britt K, Marini KD, Falzon J, Thomas DM, et al. Next-generation sequence analysis of cancer xenograft models. PLoS One. 2013;8(9):e74432.

Kinsella MD, Hinrichs B, Cohen C, Siddiqui MT. Highlighting nuclear membrane staining in thyroid neoplasms with emerin: review and diagnostic utility. Diagn Cytopathol. 2013;41(6):497-504.

Olson MT, Siddiqui MT, Ali SZ. The differential diagnosis of squamous cells in pancreatic aspirates: from contamination to adenosquamous carcinoma. Acta Cytol. 2013;57(2):139-46.

Birk AV, Liu S, Soong Y, Mills W, Singh P, J Warren D, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-61.

Sodikoff JB, Johnson HL, Lewis MM, Garud SS, Bharmal SJ, Keilin SA, et al. Increased diagnostic yield of endoscopic ultrasound-guided fine needle aspirates with flow cytometry and immunohistochemistry. Diagn Cytopathol. 2013;41(12):1043-51.

Srivastava DB, Leon K, Osmundson J, Garner AL, Weiss LA, Westblade LF, et al. Structure and function of CarD, an essential mycobacterial transcription factor. Proc Natl Acad Sci U S A. 2013;110(31):12619-24.

Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, et al. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013;37(10):1518-31.

Kim K-, Godarova A, Seedle K, Kim M-, Ince TA, Wells SI, et al. Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner. PLoS One. 2013;8(12):e80590.

Lin P-, Chiu Y-, Banerjee S, Park K, Mosquera JM, Giannopoulou E, et al. Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer Res. 2013;73(3):1232-44.

Chiron D, Martin P, Di Liberto M, Huang X, Ely S, Lannutti BJ, et al. Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1. Cell Cycle. 2013;12(12):1892-900.